Cholesterol does not affect the toxicity of amyloid β fragment but mimics its effect on MTT formazan exocytosis in cultured rat hippocampal neurons

Neuroscience Research

Volumn 35, Issue 3, 1999, Pages 165-174

  Abe, Kazuho ^a   Saito, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

3 (4,5 Dimethylthiazol 2 yl) 2,5 diphenyltetrazolium bromide; Amyloid protein; Cell survival; Cholesterol; Exocytosis; Methyl cyclodextrin; Rat hippocampal neurons

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALCOHOL; AMYLOID BETA PROTEIN; BETA CYCLODEXTRIN DERIVATIVE; CHOLESTEROL; DIMETHYL SULFOXIDE; FORMAZAN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; EXOCYTOSIS; HIPPOCAMPUS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SOLUBILIZATION;

AMYLOID BETA-PROTEIN; ANIMALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CHOLESTEROL; EXOCYTOSIS; FORMAZANS; HIPPOCAMPUS; INDICATORS AND REAGENTS; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; TETRAZOLIUM SALTS;

EID: 0032759230     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(99)00048-6     Document Type: Article

References (27)

1. 2+-dependent late phase. J. Neurochem. 67:1996;2074-2078.
2. Abe K., Kato M., Saito H. Congo red reverses amyloid β protein-induced cellular stress in astrocytes. Neurosci. Res. 29:1997;129-134.
3. Abe K., Saito H. Amyloid β protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes. Neurosci. Res. 31:1998;295-305.
4. Abe K., Saito H. Both oxidative stress-dependent and independent effects of amyloid β protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay. Brain Res. 830:1999;146-154.
5. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
6. Criado M., Eibl H., Barrantes F.J. Effects of lipids on acetylcholine receptor: essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles. Biochemistry. 21:1982;3622-3629.
7. Fong T.M., McNamee M.G. Stabilization of acetylcholine receptor secondary structure by cholesterol and negatively charged phospholipids in membranes. Biochemistry. 26:1987;3871-3880.
8. Grunze M., Forst B., Deuticke B. Dual effect of membrane cholesterol on simple and mediated transport processes in human erythrocytes. Biochim. Biophys. Acta. 660:1980;860-868.
9. Hertel C., Hauser N., Schubenel R., Seilheimer B., Kemp J.A. β-Amyloid-induced cell toxicity: enhancement of 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheyltetrazolium bromide-dependent cell death. J. Neurochem. 67:1996;272-276.
10. Kaneko I., Yamada N., Sakuraba Y., Kamenosono M., Tutumi S. Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at ser residue. J. Neurochem. 65:1995;2585-2593.
11. Kato M., Saito H., Abe K. Nanomolar amyloid β protein-induced inhibition of cellular redox activity in cultured astrocytes. J. Neurochem. 68:1997;1889-1895.
12. Kilsdonk E.P.C., Yancey P.G., Stoudt G.W., Bangerter F.W., Johnson W.J., Phillips M.C., Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 270:1995;17250-17256.
13. Liu Y., Peterson D.A., Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheyltetrazolium bromide (MTT) reduction. J. Neurochem. 69:1997;581-593.
14. Liu Y., Schubert D. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J. Neurochem. 69:1997;2285-2293.
15. Liu Y., Peterson D.A., Schubert D. Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc. Natl. Acad. Sci. USA. 95:1998;13266-13271.
16. Mattson M.P., Tomaselli K.J., Rydel R.E. Calcium-destabilization and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621:1993;35-49.
17. Mitchell D.C., Straume M., Miller J.L., Litman B.J. Modulation of metarhodopsin formation by cholesterol-induced ordering of bilayer lipids. Biochemistry. 29:1990;9143-9149.
18. Neufeld E.B., Cooney A.M., Pitha J., Dawidowicz E.A., Dwyer N.K., Pentchev P.G., Blanchette-Mackie E.J. Intracellular trafficking of cholesterol monitored with a cyclodextrin. J. Biol. Chem. 271:1996;21604-21613.
19. Ohtani Y., Irie T., Uekama K, Fukunaga K., Pitha J. Differential effects of α-, β- and γ-cyclodextrins on human erythrocytes. Eur. J. Biochem. 186:1989;17-22.
20. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vivo aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
21. Poirier J. Apolipoprotein E in animal model of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
22. Shearman M.S., Regan C.I., Iversen L.L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1994;1470-1474.
23. Shearman M.S., Hawtin S.R., Tailor V.J. The intracellular component of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides. J. Neurochem. 65:1995;218-227.
24. Slater T.F., Sawyer B., Strauli U. Studies on succinate-tetrazolium reductase system III: points of coupling of four tetrazolium salts. Biochim. Biophys. Acta. 77:1963;383-393.
25. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 25:1990;279-282.
26. +)-ATPase ATP hydrolyzing activity in bovine kidney. Biochemistry. 27:1988;6449-6452.
27. Zhou Y., Richardson J.S. Cholesterol protects PC12 cells from β-amyloid induced calcium disordering and cytotoxicity. Neuroreport. 7:1996;2487-2490.